Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CTRE vs SBRA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: CTRE 4 – 2 SBRA Matrix Metrics: CTRE 8 – 2 SBRA

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin), whereas SBRA carries 56.4/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin).

  • Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (56.4/100 HOLD vs. CTRE 46.6/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (66.2% vs. 18.4% operating margin) and revenue trajectory (+33.2% vs. +31.6% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CTRE vs SBRA
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.66
-1.06% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 22.3x
Beta / 30D Vol 0.14β · 28% Vol
Unified Composite Score
46.6 / 100 HOLD
Tech 42.0 Fund 45.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.3 · SMA20: $37.15 · SMA50: $37.17
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.42
-0.1% 1D
Market Cap $5.4B
TTM Revenue $924M
Forward P/E 28.2x
Beta / 30D Vol -0.01β · 31% Vol
Unified Composite Score
56.4 / 100 HOLD
Tech 43.0 Fund 56.0 Flow 74.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.2 · SMA20: $20.17 · SMA50: $19.88

6-Pillar Scorecard Institutional Category Breakdown (CTRE 4 – 2 SBRA)

Columns: Metric · CTRE · SBRA
1. Valuation Multiples CTRE
Forward P/E 22.3x 28.2x
Trailing P/E 24.0x 76.2x
PEG Ratio 1.26x 5.28x
EV / Revenue 18.6x 8.4x
2. Growth & Scale CTRE
Revenue Growth (YoY) +33.2% +31.6%
Earnings Growth (YoY) -0.8% +22.2%
TTM Revenue (USD) $615M $924M
Market Cap $9.8B $5.4B
3. Profitability & Quality CTRE
Gross Margin 95.7% 49.6%
Operating Margin 66.2% 18.4%
Net Profit Margin 59.2% 7.7%
Return on Equity (ROE) 7.7% 2.5%
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) $485M $401M
Cash Flow Margin 78.8% 43.3%
Net Cash / Leverage $1.59B Net Debt (0.39x D/E) $2.42B Net Debt (0.86x D/E)
Dividend Yield 3.90% 5.72%
5. Options & Positioning SBRA
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 24.7% (10th %ile) 21.6% (6th %ile)
Put/Call OI Skew 6.12x (Put-Skewed) 0.11x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat SBRA
OpEx & R&D Intensity 29.5% of Rev ($182M) 31.2% of Rev ($288M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CTRE (8) vs SBRA (2)
Institutional Metric CTRE SBRA Criterion Row Edge
Market Capitalization
Scale
$9.8B $5.4B Larger Scale CTRE
Trailing P/E Ratio
Valuation
24.0x 76.2x Lower Multiple CTRE
Forward P/E Ratio
Valuation
22.3x 28.2x Lower Multiple CTRE
Revenue Growth (YoY)
Growth
+33.2% +31.6% Higher Growth CTRE
Operating Margin (TTM)
Profitability
66.2% 18.4% Higher Margin CTRE
Net Profit Margin
Profitability
59.2% 7.7% Higher Margin CTRE
Return on Equity (ROE)
Capital Efficiency
7.7% 2.5% Higher ROE CTRE
52-Week Range Position
Momentum
33% ($35–$44) 55% ($18–$23) Stronger Trend SBRA
Beta / 30D Volatility
Risk Regime
0.14β · 28% Vol -0.01β · 31% Vol Lower Realized Risk CTRE
Unified Institutional Score
Composite Signal
46.6 / 100 (HOLD) 56.4 / 100 (HOLD) Higher Composite SBRA
Trailing 12M Revenue (USD)
Operating Scale
$615M $924M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.7% 49.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.26x PEG · 18.6x EV/Rev 5.28x PEG · 8.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$485M ($1.59B Net Debt (0.39x D/E)) $401M ($2.42B Net Debt (0.86x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBRA +2.53 pp
CTRE: +3.05% · SBRA: +5.58%
3M Horizon SBRA +4.6 pp
CTRE: -4.16% · SBRA: +0.44%
6M Horizon SBRA +6.84 pp
CTRE: -9.28% · SBRA: -2.44%
1Y Horizon SBRA +3.92 pp
CTRE: +5.39% · SBRA: +9.31%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period CTRE Revenue SBRA Revenue CTRE Op. Margin SBRA Op. Margin Margin Leader
Q3 '25 $420M $760M 57.1% 31.3% CTRE
Q4 '25 $430M $850M 58.7% 30.5% CTRE
Q1 '26 $470M $890M 58.0% 30.8% CTRE
Q2 '26 $490M $940M 53.8% -13.6% CTRE
Q3 '26 $540M $1.00B 57.3% 25.6% CTRE

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CTRE CONSOLIDATION
83d in phase · OBV DISTRIBUTION
Current IV 24.7%
IV Percentile 10th %ile
Put/Call OI Skew 6.12x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
79d in phase · OBV DISTRIBUTION
Current IV 21.6%
IV Percentile 6th %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SBRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published
SBRA Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($288M)
90D Engineering Disclosures 0 Published

Investor FAQ CTRE vs SBRA Key Questions & Quantitative Answers

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin), whereas SBRA carries 56.4/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (56.4/100 HOLD vs. CTRE 46.6/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (66.2% vs. 18.4% operating margin) and revenue trajectory (+33.2% vs. +31.6% YoY).

CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), CTRE cumulative revenue shifted +28.6% while SBRA shifted +31.6%. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.

CTRE screens cheaper on headline valuation multiples. CTRE trades at 22.3x Forward P/E, 24.0x Trailing P/E, 1.26x PEG, and 18.6x EV/Revenue (78.8% FCF margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus SBRA (2.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CTRE carries 24.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.14β · 28% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.